(HealthDay News) — A chocolate male enhancement product is being pulled from store shelves after federal health officials found it contains a hidden prescription drug. The company — USALESS.COM, based ...

Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published ...

For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or nephrectomy, according to a study published online March 3 in Radiology. Johanne ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

In this phase 2 study, researchers explored the safety and efficacy of combining serplulimab with a PD-1 inhibitor in non-clear cell renal cell carcinoma.

Whether BCG strains other than BCG TICE are safe and effective for treating high-grade NMIBC warrants rigorous testing.

Since the 1990s, the FDA has collected fees from drug companies to help pay for stepped-up staffing enable faster reviews of new prescription drugs and vaccines. In turn, the agency must meet certain ...

Low-dose zoledronic acid appeared safe among older patients with hip fracture and advanced chronic kidney disease.

The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.

In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.

The LITESPARK-022 study tested belzutifan, an oral small-molecule inhibitor of hypoxia-inducible factor-2α (HIF-2α) targeting angiogenesis, in combination with standard of care pembrolizumab as ...

(HealthDay News) — Adult patients with cancer who experience a new-onset mental health disorder (MHD) have an increased risk for death, according to a study published online Feb. 23 in Cancer.